Fi n a l

og

pr

3

ram

S EPT .
03-06

WITH SUPPORT OF THE JOURNAL

www.congresseums.com©overcome

2

20

1

Dear colleagues and friends,
EUMS 2023 will take place in Paris from Sept 3rd – 6th, 2023.
After a few years of date instability mainly due to the COVID crisis, the EUMS board decided to stabilize the agenda to
the first week of September. Even if we understand that many of you will miss Paris at Christmas time, we are sure you
will enjoy the French capital’s softness and tranquillity at that time. Moreover, rugby fans will be at the right place tofollow the rugby world cup, which will start on September 8th in Paris with the France-New Zeeland game.
Last year in Hanover, the EUMS group headed by Jan Schmitto experienced a very active conference, bringing together
more than 600 caregivers, engineers and other specialists involved in the field of advanced heart failure and mechanicalcirculatory support.
The 2023 meeting will start on Sunday, Sept. 3rd in the afternoon with two major events: 4 EUMS Academy workshops
in parallel with advanced courses addressing temporary support, LVAD complication management, R&D engineeringand VAD coordinator work, followed by a 2 hours rapid-fire abstract session. Then we will have two and half days ofdifferent session formats: key leader presentations, meet the expert, round table discussions, innovation overview…
Of course, a nice Parisian dinner will be proposed.
As usual, the main objective of the meeting is to facilitate experience exchange, knowledge sharing, networking,science, questioning, and collaborative work between cardiologists, intensivists, surgeons, electrophysiologists, VAD
coordinators, nurses, engineers, and industry representatives. You will also have the opportunity to discuss with themost famous experts in the field.
As many of you already know, Paris EUMS gives high importance to temporary support and we will discuss and debate
percutaneous LVAD, ECMO, temporary BIVAD… A special session will be dedicated to temporary respiratory support.
Of course, advanced heart failure management with the most recent evolutions will be addressed and a full session will
focus on the interface between electrophysiology, CRT, novel technologies and short- and long-term MCS trying to fill
the therapeutic and communication gap between the two fields.
Over the last few years, the MCS field underwent a huge modification, particularly with a dramatic reduction of gameplayers and a worldwide shrinking of implantation numbers despite the expected increase in the market. We will favour
an interactive discussion between several important game players from caregivers to business specialists trying tounderstand the reasons for the recent slowing down and how to solve the ongoing lack of confidence in the therapy
from many cardiologists and financial issues. Heterogeneity in the outcome, improved management and best practices
standards will also be addressed at the upcoming EUMS conference in Paris.
Technical issues related to the growing field of GUCH will be discussed and we will have KOL debating interactive
complex cases. Finally, we will look toward the future with innovation, update sessions, and EUMS task expansion.
Year after year, we worked all together to make EUMS the most active place to improve global knowledge in MCS. We
look forward to welcoming you to EUMS 2023 and hope you will enjoy sharing with us this fascinating field in one of
the most beautiful towns in the world.
Pascal Leprince

Aly El Banayosy

Daniel Zimpfer

Jan D. Schmitto

SCIENTIFIC COMMITTEE

2

N. AISSAOUI, Paris – FR
A. El BANAYOSY, Oklahoma City – USA
G. LAUFER, Vienna – AT
P. LEPRINCE, Paris – FR

A. RUHPARWAR, Hanover – DE
J. D. SCHMITTO, Hanover – DE
M. SLEPIAN, Tucson – US
D. ZIMPFER, Graz – AT

SUNDAY 3 SEPTEMBER 2023
EUMS Academy Workshop

AMPHITHEATRE

14:00
15:00

15:00
16:00

R&D: from idea
to conception.
Engineeringand financial issues
Challenging issues
regarding training
on acute
and chronic heart
failure acrossthe world

16:00
16:30
16:30
18:30

18:45
20:30

Room
INVALIDESRoom
LOUVRE-PALAIS
ROYAL

Room
CONCORDE

Temporary support
perfectioning course:
Temporary LVAD, RVAD,
BIVAD, ECMO, ECPELLAVAD early
and latecomplication:
how to manage?

VAD coordinatormeeting
EUMS / ICCAC
sessionCoffee BreakRapid-Fire
Abstracts
SessionWelcome cocktail reception
Opening of the Industrial Exhibitionwww.congresseums.com

3MONDAY 4 SEPTEMBER 2023
AMPHITHEATRE
09:00
09:10

Welcome address

09:10
11:00

Session 1
Advanced heart failure management: edge of tomorrow

11:00
11:30

Coffee Break

11:30
13:00

Session 2
Meet the experts: interactive session

13:00
14:00

Lunch Break

14:00
16:00

Session 3
Electrophysiology, CRT and MCS: collaborative work?

16:00
16:30

Coffee Break

16:30
18:00

Session 4
Pediatric and grown-up congenital heart disease and MCS

18:00
19:00

Registries report

20:00
00:00

Congress Dinner[
4

GETINGE WORKSHOPS LED
BY THE PRATICO SANTÉ TEAMDEMO BOX IN THE EXHIBITION HALL»TUESDAY 5 SEPTEMBER 2023
AMPHITHEATRE
08:30
10:30

Session 5
Cardiogenic shock and short term support

10:30
11:00

Coffee Break

11:00
13:00

Session 6
Deep inside durable MCS

13:00
14:00

Lunch Break

14:00
16:00

Session 7
Gaps and opportunities: round tablewith clinicians and R&D and business people

16:00
16:30

Coffee Break

16:30
18:30

Session 8
Innovation

MONDAY & TUESDAY
10:00-10:45 VA ECMO trouble shooting
11:30-12:15 VV ECMO trouble shooting
14:00-14:45 ECPR case scenario through serious gamewww.congresseums.com

5

WEDNESDAY 6 SEPTEMBER 2023
AMPHITHEATRE

6

08:00
08:45

Session 9
Selected cases

08:45
10:05

Session 10
Mechanical devices in lung report

10:05
10:30

Coffee Break

10:30
11:50

Session 11
Advanced heart failure therapies, alternative treatments?

11:50
12:15

EUMS-Closing ceremony

SUNDAY 3 SEPTEMBER 2023
EUMS ACADEMY WORKSHOPS

14:00 CEST
16:00

TEMPORARY SUPPORT PERFECTIONING COURSE:
TEMPORARY LVAD, RVAD, BIVAD, ECMO, ECPELLARoomINVALIDES

In four rooms in parallel, EUMS academy workshops offer the following teaching sessions:n VAD coordinator: EUMS/ICCAC sessionn 4 interactive cases on temporary devices
n 4 interactive cases on VAD early and late complication
n R&D: from idea to conception

4 cases, 30 minutes each, with interactive voting time and panel discussion
Chairs: A. EL BANAYOSY, Oklahoma City – US, A. COMBES, Paris – FRn How to minimize Leg ischemia in peripheral ECMO practically
S. HOSSEINI, Tehran – IRn A long way to go...
G. LEBRETON, Paris – FRn Percutaneous RVAD associated with HMIII
F. KHALIEL, Riyad – SAn Options for VA ECMO patients: durable MCS – Transplant and beyond
A. EL BANAYOSY, Oklahoma City – US

Room LOUVREPALAIS ROYAL

14:00 CEST VAD EARLY AND LATE COMPLICATION:
15:00
HOW TO MANAGE?

3 presentations, 30 minutes each, with interactive voting time, and panel discussion
Chairs: J.D. SCHMITTO, Hanover – DE, U. JORDE, New York – US
Indication challenging casen Outflow graft thrombosis
M. MORSHUIS, Bad Oeynhausen – DEn Tricuspid valve management
G. WIESELTHALER, San Francisco – USn Aortic valve regurgitation
C. BERMUDEZ, Philadelphia – US

AMPHITHEATRE

14:00 CEST R&D: FROM IDEA TO CONCEPTION, ENGINEERING
15:00
AND FINANCIAL ISSUESROUND TABLE
Chairs: R. KORMOS, Austin – US, D. ZIMPFER, Graz – AT
Panelists: P. LEPRINCE, Paris – FR, S. PIAT, Vélizy-Villacoublay – FR, D. LOISANCE, Creteil – FR,
S. SCHUELER, Newcastle – GB, J. LONG, Oklahoma – US, L. FRESIELLO, Enschede – NL

AMPHITHEATRE

15:00 CEST CHALLENGING ISSUES REGARDING TRAINING ON ACUTE AND CHRONIC HEART
16:00
FAILURE ACROSS THE WORLDROUND TABLE
Chairs: S. TSUI, Cambridge – GB, N. AISSAOUI, Paris – FR
Panelists: J. RIEBANDT, Vienna – AT, C. DELMAS, Toulouse – FR, G. DOGAN, Hanover – DE,
N. URIEL, New York – US, E. RAME, Pennsylvania – US, G. SAIYDOUN, Paris – FR
P. LEPRINCE, Paris – FR
7

SUNDAY 3 SEPTEMBER 2023

Room CONCORDE

14:00 CEST VAD COORDINATOR MEETING
16:00
EUMS /ICCAC SESSION

Chairs: A. WOODS, Newcastle upon Tyne – GB, K. HOMANN, Hanover – DEn You have the power! How VAD Coordinators help shape MCS
Aim would be to look at how a VAD Coordinator impacts a VAD programme and how this can shape
the world of MCS. Aim to promote VAD coordinator research. Look at how the coordinator role may
change with the progression of short-term devices. Are we more advanced heart failure practitioners.
J. HAJJ, Charleston - US
n The new kids on the block: Use of ARBNI and SLGT2 inhibitors in MCS therapy
A review of how ARBNU and SLGT2 inhibitors will impact the world of MCS and the evidence
behind it.
E. RAME, Pennsylvania – USn Mum, Dad; Are we there yet? Single centre experience of paediatric LVAD implants
Freeman paediatrics experience of durable MCS therapy and the challenges this brings
C. MCGRAITH, Newcastle Upon Tyne – GBn Me, myself and VAD: Patients are the untapped knowledge source
Let’s use the knowledge of carers and patients to help shape best practice in our field
S. KORE, Manchester – GBn Short or long run: The use of short term MCS versus durable MCS, are times changing?
A pro and con debate one person promoting the use of short-term devices the other promoting
durable devices
K. VANDERMISSEN, Leuven - BE – F. MULLER, Sankt Ingbert – DEn You look different to me: The role of the VAD coordinator from a surgeon’s perspective
We often hear VAD coordinators talking about their role but, how is the role of the VAD
coordinator viewed from those we work alongside
J. HANKE, Hanover – DEn Discussion and Q&A with speakers
16:00 – 16:30 COFFEE BREAK

AMPHITHEATRE

16:30 CEST
RAPID-FIRE ABSTRACTS SESSION
18:30

8

Chairs: D. ZIMPFER, Graz – AT, J.D. SCHMITTO, Hanover – DE, S. TSUI, Cambridge – GBn Comparative impact of Impella, central VA ECMO and ECPELLA on myocardial oxygen
consumption
K. YASTREBOV, Sydney – AUn Multicenter development and validation of a machine learning model to predict myocardial
recovery during LVAD support: the UCAR Score
S. DRAKOS, Salt Lake City – USn Left ventricle assist device positioning: a comprehensive evaluation
I. HARTYÁNSZKY, Budapest – HU
n Outcomes and complications after LVAD implantation
G. WASILEWSKI, Krakow – PLn VA-ECMO for hemodynamic support in massive and sub-massive pulmonary embolism –the path forward
P. BARRETT, Atlanta – USn Prolonged oxygenator usage for VV ECMO FOR COVID ARDS: a clinical experience M. OZGUR, Istanbul – TRn Conundrum after peripheral VA-ECMO and pulmonary embolectomy: a “switch” in time saves nine
S. AZIZ,Washington – USn Heart support pump – RAP-P, Rotary Assisted Pulsatile – Pump
F.-H. HORN, Tating – DEn Long-term outcomes following explantation of durable left ventricular assist device
A.M. JAKSTAITE, Hanover – DEn Change in wound care management reduces cannula site infection rate in patients withparacorporeal VAD
E. WOODS, London – UKn Phosphodiesterase type 5 inhibitor use is associated with reduced all-cause mortality and ischemic
stroke at 24 months postimplant in contemporary centrifugal flow left ventricular assist devices
E. RAME, Pennsylvania – USn Realheart TAH –a preclinical update of the world’s first 4-chamber artificial heart
I.L. PERKINS, Västeras – SE

MONDAY 4 SEPTEMBER 2023
WELCOME ADDRESSAMPHITHEATRE

09:00 CEST
09:10

09:10 CEST
11:00

SESSION 1 – ADVANCED HEART FAILURE MANAGEMENT: EDGE OF TOMORROW
Chairs: P. LEPRINCE, Paris – FR, G. LAUFER, Vienna – AT, A. RUHPARWAR, Hanover – DEBest Abstract: Multicenter development and validation of a machine learning risk model topredict right ventricular failure following mechanical circulatory support: the STOP-RVF score
S. DRAKOS, Salt Lake City – USn Debate: New drugs improve short-term outcomes but delay patient referral for advanced heart
failure treatment (MCS, transplantation).
- AgreeR. KORMOS, Austin – US
- Disagree
J. BAUERSACHS, Hanover – DEn Heart failure cardiogenic shock
D. BARAN, Florida – USn Early recognition of changes in PAP by CardioMEMS helps in early identification of patients that need
LVAD therapy and post-implant follow-up
A. ALSHEHRI, Riyad – SA

AMPHITHEATREnn

Levosimendan as a bridge to surgery in severe chronic heart failure

A. SHIRYAEV, Moscow – RU

l Panel discussion with all the speakers

DEMO
BOX
ExhibitionHall

10:45 CESTGETINGE WORKSHOP – VA ECMO TROUBLE SHOOTING
1130

Pre-registration required

11:00 – 11:30 COFFEE BREAK & EXHIBITION VISIT
11:30 CEST
13:00

SESSION 2 – MEET THE EXPERTS

AMPHITHEATRE

Chairs: J.D. SCHMITTO, Hanover – DE, A. COMBES, Paris – FRInteractive session, with panelists:
E. RAME, Pennsylvania – US, A. EL BANAYOSY, Oklahoma City – US, G. LEBRETON, Paris – FR,
A. WOODS, Newcastle – GB, J. RIEBANDT, Vienna – AT, M. MORSHUIS, Bad Oeynhausen – DEwith interactive voting time
Escalating and de-escalatingn MCS post transplantn LVAD and small ventriclenA. EL BANAYOSY, Oklahoma City – US
G. LEBRETON, Paris – FR
M. MORSHUIS, Bad Oeynhausen – DE
9

MONDAY 4 SEPTEMBER 2023

DEMO
BOX
Exhibition
Hall

11:45 CESTGETINGE WORKSHOP – VV ECMO TROUBLE SHOOTING
12:30

Pre-registration required

13:00 – 14:00 LUNCH BREAK & EXHIBITION VISIT

DEMO
BOX
ExhibitionHall

14:00 CESTGETINGE WORKSHOP – EPCR CASE SCENARIO THROUGH SERIOUS GAME
14:45

Pre-registration required

14:00 CEST
16:00

SESSION 3 – ELECTROPHYSIOLOGY, CRT AND MCS: COLLABORATIVE WORK?

AMPHITHEATRE

Chairs: J. BAUERSACHS, Hanover – DE, U. JORDE, New York – US
Debate: All CRT non-responders should be addressed for LVAD evaluation- Pro
N. URIEL, New York – US
- Con
E. SIMSEK, Izmir – TRn Temporary support and malignant arrhythmias
M. PINETON DE CHAMBRUN, Paris – FRn Ventricular rhythm disturbance issues in MCS patients
U. JORDE, New York – USn How to manage AF in heart failure and LVAD patients
M. LA MEIR, Brussel – BEl Panel discussion with all the speakers
16:00 – 16:30 COFFEE BREAK & EXHIBITION VISITAMPHITHEATRE

16:30 CESTSESSION 4 – PEDIATRIC AND GROWN-UP CONGENITAL HEART DISEASE AND MCS
18:00

18:00 CEST
19:00

10

Chairs: D. ZIMPFER, Graz – AT, G. WIESELTHALER, San Francisco – US, E. GOLUKHOVA, Moscow - RU
n Best Abstract: Outcome after ECMO therapy in Norwood patients before the bidirectional Glenn
operation
F. SEEBER, Linz – ATn The use of magnetically levitated continuous flow LVAD in paediatrics:“Russian experience”
K. SHATALOV, Moscow – RU
n HMIII in smaller patients
U. KERVAN, Ankara – TRn MCS in GUCH patients: technical issues
D. ZIMPFER, Graz – ATn TAH in GUCH patients
F. ARABIA, Phoenix – USl Panel discussion with all the speakers

REGISTRIES REPORTAMPHITHEATREMONDAY 4 SEPTEMBER 2023

20:00 CEST

Chairs: B. MEYNS, Leuven – BE, J. HANKE, Hanover – DE, G. LEBRETON, Paris – FREuromacs
Francemacs
n Imacsn Elongate registrynnP. MOHASCI, Zürich – CH
M. KINDO, Strasbourg – FR
E. RAME, Pennsylvania – US
N. AISSAOUI, Paris – FR

CONGRESS DINNER

www.congresseums.com

11

TUESDAY 5 SEPTEMBER 2023
JOGGING: ALONG THE SEINE RIVER

08:30 CEST
10:30

SESSION 5 – CARDIOGENIC SHOCK AND SHORT TERM SUPPORTAMPHITHEATRE

06:15 CEST

Chairs: N. AISSAOUI, Paris – FR, A. EL BANAYOSY, Oklahoma City – US, D. BARAN, Florida – USn VA ECMO and Impella trials in CS: update
A. COMBES, Paris – FRn Mid-term survival after VA ECMO weaning: unjustified high rate of death?
P. LEPRINCE, Paris – FRn Left ventricle reverse remodeling with Impella 5.5: an animal study
B. MEYNS, Leuven – BEl Panel discussion with all the speakers
n Debate: What is the best option for stable patients on VA ECMO with poor potential for recovery?
- Cardiac transplantation
E. EPAILLY, Strasbourg – FR
- Long-term MCS (LVAD, BIVAD, TAH)
A. RUHPARWAR, Hanover – DEn Debate: From ECMO to LVAD
- Direct LVAD implantation is the best option
D. SAEED, Krefeld – DE
- Intermediary support with Impella is the best option
Y. BARAC, Tel Aviv – IL

DEMO
BOX
ExhibitionHall

10:00 CESTGETINGE WORKSHOP – VA ECMO TROUBLE SHOOTING
10:45

Pre-registration required

10:30 – 11:00 COFFEE BREAK & EXHIBITION VISITAMPHITHEATRE

11:00 CEST
13:00

SESSION 6 – DEEP INSIDE DURABLE MCS
Chairs: J.D. SCHMITTO, Hanover – DE, J. LONG, Oklahoma – US, S. SCHUELER, Newcastle – GBn Best Abstract: Pump-LV interaction during long-term support with the HeartMate 3 LVAD
F. CONSOLO, Milano – IT
n Keynote lecture. AI-driven revolution: impact on Mechanical Circulatory Support world
A. KILIC, South Carolina – USn ISHLT guidelines 2023: what’s new
D. SAEED, Krefeld – DEn From momentum 3 trial: centre-based criteria for improving outcome? N. URIEL, New York – USn Myocardial recovery: what have we learned and future directions
S. DRAKOS, Salt Lake City – USn Medicolegal issues
M. SLEPIAN, Tucson – USl Panel discussion with all the speakers
n

ROUND TABLE

Chairs: J. LONG, Oklahoma – US
What future for durable LAVD and how to energize the field?
Technical, market, cardiologist, surgeon, and financial issues: difference among continentsl Panel discussion with all the speakers
12

TUESDAY 5 SEPTEMBER 2023

DEMO
BOX
ExhibitionHall

11:30 CESTGETINGE WORKSHOP – VA ECMO TROUBLE SHOOTING
12:15

Pre-registration required

13:00 – 14:00 LUNCH BREAK & EXHIBITION VISIT

Pre-registration required

14:00 CEST
16:00

SESSION 7 – GAPS AND OPPORTUNITIESAMPHITHEATRE

DEMO
BOX
ExhibitionHall

14:00 CESTGETINGE WORKSHOP – VV ECMO TROUBLE SHOOTING
14:45

Chairs: D. ZIMPFER, Graz – AT, M. SLEPIAN, Tucson – US, B. MEYNS, Leuven – BEn Best Abstract: Outcome of CentriMag™ extracorporeal mechanical circulatory support use incritical cardiogenic shock (INTERMACS 1) patients: Manchester experience
M. JAIN, Manchester – UKn Unleash the potential: Novel HeartMate 3 pump monitoring for improved patient care
T. SCHÖGLHOFER, Vienna – ATn In silico and in vitro simulation to support monitoring and controls development for MCSs
L. FRESIELLO, Enschede – NLn ROUND TABLE – with clinicians, R&D and business people
Chairs: the two previous speakers, and the two speakers below.
Leader: M. SLEPIAN, Tucson US
Why LVAD still looks like LVAD and what will lead to change?
S. SCHUELER, Newcastle upon Tyne – GBn How far miniaturization of VADs is possible?
T. SNYDER, Clichy – FRn Could a TAH definitely challenge current LVAD?
J. LONG, Oklaoma – USl Panel discussion with all the speakers
n16:00 – 16:30 COFFEE BREAK & EXHIBITION VISIT

www.congresseums.com

13

TUESDAY 5 SEPTEMBER 2023

AMPHITHEATRE

16:30 CEST
18:30

14

SESSION 8 – INNOVATION
Chairs: M. STRUEBER, Memphis – US, P. LEPRINCE, Paris – FRn Best Abstract: Advantages of 3D modeling in left ventricular assist device implantation forcomplex anatomical cases
I.-R. BARABÁS, Budapest – HU
n Speed up your patient’s blood management with autologous platelets:
same™ by i-SEP the new IOCS game changer
A. MANSOUR, Rennes – FRn Cleveland Clinic continuous-flow TAH
J. H. KARIMOV, Cleveland – USn The broader scope of innovation
R. MOCK, ABBOTT, Plano – USn The AdjuCor reBEAT-Device: Translational steps of a non-blood-contacting MCS towards thefirst-in-Human experience
B. SCHMACK, Hanover – DEn Berlin Heals C-MIC Cardiac Microcurrent Therapy for Chronic Heart Failure –status update
E. RAME, Pennsylvania – USn A Physiologic Heart Replacement Therapy for advanced heart failure patients
P. JANSEN, CARMAT, Vélizy – FRn CorWave: A synchronized pulsatile LVAD with autonomous control features – A progress update
T. SNYDER, Clichy – FRn FineHeart FlowMaker: a small, fully implantable, intra-cardiac pump, demonstrates the ability
to induce durable recovery in HF
L. BARANDON, Bordeaux – FRn Corheart 6: small and innovative VAD technology for the future of HF therapy
J.D. SCHMITTO, Hanover – DEn Design and preliminary use of a new Venticular Assist Device
N. DONG, Wuhan – CN

WEDNESDAY 6 SEPTEMBER 2023

AMPHITHEATRE

08:00 CEST
08:45

AMPHITHEATRE

08:45 CEST
10:05

SESSION 9 – SELECTED CASES
Chairs: G. LEBRETON, Paris – FR, M. STRUEBER, Memphis – USn Decision tree in biventricular failure: escalation and de-escalation
G. DOGAN, Hanover – DEn Mechanical circulatory support with Impella in septic shock
Z. HAIDARI, Essen – DEn LVAD in ischemic cardiomyopathy: an unexpected recovery
G. KHUBULAVA, Saint-Petersburg – RU

SESSION 10 – MECHANICAL DEVICES IN LUNG SUPPORT
Chairs: Y. BARAC, Tel Aviv – IL, E. EPAILLY, Strasbourg – FRn Artificial lung: animal studies
M. ANRAKU, Tokyo – JPn MCS and pulmonary embolism
O. SANCHEZ, Paris – FRn MCS and pulmonary hypertension
O. MERCIER, Le Plessis-Robinson – FRn MCS and lung transplantation
M. STRUEBER, Memphis – USl Panel discussion with all the speakers
10:05 – 10:30 COFFEE BREAK & EXHIBITION VISITAMPHITHEATRE

10:30 CEST
11:50

11:50 CEST
12:15

SESSION 11 – ADVANCED HEART FAILURE THERAPIES: ALTERNATIVE TREATMENTS?
Chairs: D. ZIMPFER, Graz – AT, J.D. SCHMITTO, Hanover – DE, A. EL BANAYOSY, Oklahoma City – US,
P. LEPRINCE, Paris – FRn Heart failure in Women
M. AL QASEER, Dammam – SA
n Stem cell therapy: any hope in advanced heart failure management?
P. MENASCHÉ, Paris – FRn Xenotransplantation: how the first in-man implantation will impact the field?
M. MOHIUDDIN, Baltimore – US

CLOSING SESSION

www.congresseums.com

15

NOTES

16

NOTES17

PARTERS 
ACKNOWLEDGEMENTS

www.congresseums.com

GENERAL INFORMATION 
SUMMIT VENUENOVOTEL PARIS CENTRE TOUR EIFFEL
61 Quai de Grenelle, 75015, Paris, France
Tel.: +33 1 40 58 20 00

LOGISTICAL ORGANIZATION AND REGISTRATIONOVERCOME: 13-15, rue des Sablons - 75116 PARIS, France
Ph: +33(0)1 40 88 97 97
Fax: +33 (0)1 43 59 76 07
E-mail: eums@overcome.fr

REGISTRATIONOn site registration
Physician/Engineer

650 €Nurse/Perfusionist/Resident

250 €Student

125 €Congress Dinner

100 €The registration fee includes:
Access to the scientific sessions and the exhibition, daily breaks, and Congress documents.
Cancellation Policy:
To request a refund, participants must return their registration receipt with a written request to Overcome, before
1st August 2023.
There will be a cancellation fee of € 60 (incl. VAT). No refund will be possible after this date.
The closing date for individual registration is 25 August 2023. After this date, registration will be only accepted on-site.

ACCOMMODATION
A limited number of rooms at preferential rates have been booked for the EUMS delegates.
For individual reservations, you can book directly online through your registration profile.
For a company or third-party reservation, please send your request to the Overcome Housing Department at:
Tel. : +33(0)1 40 88 97 97 or e-mail: eumshousing@overcome.fr

EXHIBITION
A large exhibition will take place in the heart of the event, hosting industry partners.

TRANSPORTATION
Event: 17th European Mechanical Circulatory Support Summit
Event ID: 40044AF, valid from 27 August 2023 to 13 September 2023
Attractive discounts, up to -15%, on a wide range of public fares on all AIR FRANCE, KLM and their code-shared
flights worldwide,on the regular full fare in economy class for a round-trip journey (subject to conditions).
To book your electronic ticket, visit globalmeetings.airfranceklm.com and enter the event ID code to access thediscounted AIR FRANCE-KLM Global Meetings & Events fares.
19

Impella®
Heart Pump
Stabilize. Unload. Recover.

Impella 5.5® with SmartAssist®
Minimally Invasive Heart Pump
Delivering Full Forward Flow

Designed for Long
Duration Support
for up to 30 days

Forward Flowof 5,5 L/min
with Maximum
UnloadingEnables Heart
Recoveryheartrecovery.de